Clinical Trial Update: A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a fixed-dose combination of ezetimibe/atorvastatin versus separate ezetimibe and atorvastatin in patients with high cholesterol; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Atorvastatin 20 mg (atorvastatin)
• Ezetimibe 10 mg (ezetimibe)
• Ezetimibe/atorvastatin 10 mg/20 mg fixed-dose combination tablet (ezetimibe/atorvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2013-08-05